First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases

Overview of attention for article published in Clinical Cancer Research, June 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

policy: 1 policy source
twitter: 5 X users

patent: 2 patents
wikipedia: 5 Wikipedia pages

Citations

dimensions_citation: 383 Dimensions

Readers on

mendeley: 178 Mendeley

Summary Policy documents X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Radiopharmaceutical solutions with advantageous properties

Grant US-9433690-B1

United States of America

COMBINATION COMPRISING RADIUM-223 FOR THE TREATMENT OF CANCER

Application WO-2014095833-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.